Skip to main content
OpenTrials
Completed

NCT Number: NCT02706457

Post Intensive Care Syndrome

Barthel Index and demographic variables of patients were collected to investigate the question whether the improvements of the functionality improves the Barthel Index over the years.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical Center Leeuwarden

Leeuwarden, 8904 BR, Netherlands

About this study

idem

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years and older
  • length of stay longer than 48 hours

Exclusion criteria

  • no exclusion criteria if inclusion is correct

Treatment and study plan

Barthel index for functionality

Other

The Barthel Index for functionality is done standard in all patients after intensive care admission

Primary outcomes

  1. Difference in Barthel Index

    Time frame: from januari 2012 until decembre 2014

    barthel index is analyzed over the years 2012 - 2014

Secondary outcomes

  1. Relation between Barthel Index and length of stay in ICU

    Time frame: from januari 2012 until decembre 2014

Sponsors and collaborators

Lead sponsor

Frisius Medisch Centrum

Other

Registry information

Official study title

Do Improvements in Functionality on the ICU Give a Reduction of Post Intensive Care Syndrome

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Mar 11, 2016
Registry last updated
Apr 12, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.